The rapid global outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

With the revolution of lateral flow assay use in Point-of-Care and Over-the-Counter testing resulting from Covid-19, saliva has become an attractive sample matrix. To continue to grow lateral flow ...

Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, Covid case numbers have continued to rise across the UK in record numbers, ...

The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...

Immunoassays used for human in vitro diagnostics (IVD) often use animal-sourced antibodies to recognize specific disease markers. A small percentage of individuals, however, may have antibodies in ...